Mantaro Partners with Sparsense to Deliver High Performance Digital Image and Signal Processing... (ref http://www.sparsense.com/ onclick l...)

Mantaro Partners with Sparsense to Deliver High Performance Digital Image and Signal Processing Solutions

Date:8/20/2009

ref="http://www.sparsense.com/" onclick="linkClick( this.href );" target="_blank" title="Sparsense, Inc.">Sparsense, Inc. was launched in 2007 to develop and commercialize a novel signal processing technology that was invented by Zsolt Palotai, PhD. The company name is derived from the term "sparse sensing." The company's founders are Zsolt Palotai, PhD and Professor Andras Lorincz, who joined the venture as its Chief Technology Officer.

About Mantaro Product Development Services:
Mantaro, founded in 2001, is a turnkey product development services firm located in Germantown, MD that provides a full range of engineering design services to its clients. The technical staff comprises highly talented full-time professional engineers with a history of successful product development and innovating design experience. Mantaro serves a variety of industries including Consumer, Government, Industrial, Medical, Telecommunications, Test & Measurement, and Transportation.

# # #

Read the full story at http://www.prweb.com/releases/signal-processing/medical-imaging/prweb2770474.htm.

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2 3
Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
4. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
5. AtriCure to Present at Roth Capital Partners 2007 New York Conference
6. MDS to Present at Thomas Weisel Partners Healthcare Conference
7. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
8. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. National Patient Safety Foundation Partners with Vocera Communications
11. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program

Post Your Comments:

Related Image:

Mantaro Partners with Sparsense to Deliver High Performance Digital Image and Signal Processing Solutions

(Date:12/16/2009)... Dec. 16 Dale Buchanan, owner of Supreme ... have a weight loss contest for his students in the ... students are not competing for their own prize or against ... for the Tri County Humane Society in Boca ... mine loses between January 4 and February 28, 2010 I ...

(Date:12/16/2009)... in the ,70s, study finds , , TUESDAY, Dec. 15 ... the United States than it was more than 30 ... Researchers compared National Health and Nutrition Examination Survey data ... 1972 and from 8,339 black and white participants from ... years old. , The prevalence of myopia increased from ...

(Date:12/16/2009)... interval lessens complication risks , , TUESDAY, Dec. 15 (HealthDay News) ... such a profound impact on your life that you just ... new study suggests that you might want to wait at ... than 11 months could be even better. , The ... than six months, the chances of the baby dying, being ...

(Date:12/16/2009)... money to help clothe children in need. , ... ... cleaner Dryclean USA Florida , along with Atlantic Awnings of Miami, ... help clothe children in need by collecting funds on behalf of ... cards, with delivery of their clean clothes, and pamphlets requesting donations ...

(Date:12/16/2009)... 2009) Unisense FertiliTech A/S has received a further 1.6 million Euro ... the EmbryoScope™ Embryo Monitoring System in order to meet the rapidly ... by LD Pensions and Unisense A/S that continue to own each ... ... (PRWEB) December 16, 2009 -- Unisense FertiliTech A/S has received a ...

Breaking Medicine News(10 mins):Health News:Fitness Trainer Motivates Clients with Weight Loss to Help Raise Money for Animal Shelter 2 Health News:For Babies' Sake, Pregnancy Spacing Matters 2 Health News:For Babies' Sake, Pregnancy Spacing Matters 3 Health News:Pay a Dollar, Dress a Child: Helping Struggling Families with Small Donations 2 Health News:Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device 2

[0] Fitness Trainer Motivates Clients with Weight Loss to Help Raise Money for Animal Shelter [0] Nearsightedness on the Increase [0] For Babies' Sake, Pregnancy Spacing Matters [0] Pay a Dollar, Dress a Child: Helping Struggling Families with Small Donations [0] Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device

... product revenue and reduced expenses continue to drive solid cash ... (Nasdaq: WCRX ) today announced its results for ... in the quarter ended December 31, 2008 totaled $242.5 million, ... for the year ended December 31, 2008 totaled $938.1 million, ...

... Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical ... company,s premier dental pharmaceutical product. OraVerse is the ... accelerates the return to normal sensation and function ... and unnecessary lingering soft tissue anesthesia following routine ...

... Feb. 27 /PRNewswire-Asia/ -- GE Healthcare, a,leading ... suite of,Centricity solutions targeted for hospitals and ... and advanced clinical capabilities,the suite provides the ... acquisition from Dynamic Imaging. , ...

... -- endorsed by,NaturalNews, Organic Consumers Association, Life Extension ... freedom groups --,calls for an end to FDA ... Its ten provisions also call for full income ... to the psychiatric drugging of,children, the end of ...

... Nursing Productivity in the Treatment of Renal Disease , ... ... 2009 -- iSirona®, an innovative provider of data automation solutions ... agreement with NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer ...

... Healthy Directions, LLC, is proud to announce the launch of searchjointpain.com, a ... conditions and solutions. , ... Potomac, MD (PRWEB) February 27, 2009 -- ... to announce the launch of searchjointpain.com , a new informational Web ...

Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent GE Healthcare Extends Leading Web-Based Imaging Solutions to Asia Health Freedom Groups Join in Launch of Grassroots Health Revolution Petition at HealthRevolutionPetition.org iSirona Signs Reference Selling Agreement with NxStage Healthy Living Network Announces Launch of New Joint Pain Web Site

(Date:12/16/2009)... 16 The Boards of Silence Therapeutics ... to announce the merger of their businesses to ... RNAi (RNA interference). The enlarged company, to ... discovery, development and delivery technologies, a broad internal ... of intellectual property. ,, The Directors believe ...

(Date:12/16/2009)... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) ... 3 registration clinical trial for KRX-0401 (perifosine), ... / refractory multiple myeloma patients. ,, The ... to Assess the Efficacy and Safety of ... (Velcade®) and Dexamethasone in Multiple Myeloma Patients ...

(Date:12/16/2009)... 16 , ... Daniel,Tome,s Supervision and Published* in November 2009, in ... Society "Bone", Reveal new Benefits for,Peptan(TM) in Osteoporosis ... to consumer concerns regarding long-term bone health,Rousselot has ... to demonstrate,that an oral intake of Peptan(TM) may ...

Breaking Medicine Technology:Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 2 Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 3 Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 4 Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 5 Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 6 Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 2 Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 3 Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 4 Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 5 Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 6 Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 7 Published in "Bone" Journal, Scientific Researches Confirm Peptan(TM) Hydrolyzed Collagen Benefits on Bone Health 2 GBS CIDP Foundation International Appoints Patricia A Bryant as Executive Director 49276 1 GBS CIDP Foundation International Appoints Patricia A Bryant as Executive Director 49276 2 Cellular telephones to expand knowledge of health behaviors and microorganisms in adolescent males 49272 1 Cellular telephones to expand knowledge of health behaviors and microorganisms in adolescent males 49272 2 Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 1 Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 2 Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 3 Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 4

[0] Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company [0] Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma [0] Published in "Bone" Journal, Scientific Researches Confirm Peptan(TM) Hydrolyzed Collagen Benefits on Bone Health

... 2007 /PRNewswire-FirstCall/ --,CuraGen Corporation announced today that ... deacetylase (HDAC) inhibitor being,investigated for the treatment ... for the prevention of severe oral mucositis,will ... for Cancer,Research (AACR) 2007 Annual Meeting in ...

... April 11, 2007 /PRNewswire-FirstCall/ --,Advanced Magnetics today ... clinical trials of ferumoxytol as an,intravenous (IV) ... at approximately 6:00 pm EDT as posters ... in Orlando,Florida. These posters are available in ...

Other Medicine Technology:CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 2 CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 3 CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 4 Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 2 Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 3 Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 4 Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 5 Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 6 Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 7 Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 8

CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic

... With the increase in Endoscopic cases it is ... Monitor with the Surgical Light. This combination ... without having to adopt an uncomfortable pose. ... including the NUVO Monitoring System. As such ...

... This configuration offers all the performance of a ... perfectly for use in Outpatient Settings, Minor Procedure ... Mounting two single lights either side of the ... in a General OR when combining Flat Screen ...

A Western Blot Immunassay for the detection of antibodies to primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum....

Triturus® is an open and completely automated ELISA immunoassay analyzer which can perform a variety of different tests on a series of samples and process several batches simultaneously....

Medicine Products:

NUVO Surgical Light - Double Light Head Monitor Ready NUVO Surgical Light - Single Light Head Anti-Myelin Associated Glycoproteins (MAG) Western Blot Triturus® EIA Analyzer

Mantaro Partners with Sparsense to Deliver High Performance Digital Image and Signal Processing...(ref http://www.sparsense.com/ onclick l...),Health